Pancreatic Cancer
Clinical research in resectable pancreatic adenocarcinoma with risk factors, with attention to treatment strategies used around surgery and postoperative care.
- Pancreatic adenocarcinoma
- Resectable pancreatic cancer
- Risk-stratified oncology
The sponsor’s activity is centered on survival outcomes in patients managed with combined surgical and systemic treatment pathways for pancreatic malignancy.
Surgical Oncology
Research interest includes the role of surgery in patients with operable pancreatic disease, especially when integrated with other cancer-directed treatments.
- Curative-intent resection
- Perioperative cancer management
- Oncologic surgery
This area reflects a focus on clinical outcomes after operative treatment in gastrointestinal oncology.
Systemic Anticancer Therapy
The funded research involves multimodal chemotherapy approaches used before and after surgery in pancreatic cancer care.
- Neoadjuvant chemotherapy
- Adjuvant chemotherapy
- Combination treatment regimens
Interest is directed toward treatment sequencing in solid tumor oncology, particularly in patients with localized but high-risk disease.
Radiotherapy
Clinical activity also includes radiotherapy as part of preoperative treatment planning for pancreatic cancer.
- Preoperative radiation treatment
- Combined-modality therapy
- Local disease control
This domain is linked to integrated care for upper gastrointestinal tumors with surgical intent.
Survival Outcomes
The sponsor’s research landscape is strongly oriented toward overall survival assessment in patients receiving coordinated cancer treatment.
- Overall survival
- Comparative outcome analysis
- Clinical prognosis
These outcomes are examined in the context of oncology care pathways for patients with resectable pancreatic disease.
